We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Iceni Labs is an innovative enterprise that develops and deploys cutting-edge technologies to build a safer and secure future. The company takes early-stage technology from the lab to the market by partnering with leading academics, researchers, and commercial experts. It has collaborated with the UK National Health Service’s (NHS) Royal Papworth Hospital to accelerate the development of a non-contact device, SafeScan, that monitors the breathing rate of an individual remotely. Iceni Labs also conducted a one-year clinical study of the device at Royal Papworth Hospital on a sample size of 400 patients. It has been awarded Innovate UK funding to build a prototype for monitoring care home residents. The company's goal is to become globally recognised as a catalyst for successful innovation.
days to go: Expired investment: Withheld
TagDox allows the user to securely store private documents and filter them easily with the ability to add keywords. The system also allows the user to share and make the documents publically available and tagdox automatically suggests tags to improve usability. 
days to go: Expired investment: £20,025
Untied is a groundbreaking app that gathers information, claims costs and allowances, and prepares tax filings on the go. All of these can be sent to the tax authority from the application. The app connects across existing accounts, making tax sense of transactions and gives the assurance someone needs. Backed by Accenture's Fintech Innovation Lab and Barclays Techstars, the company became the first overseas winner of Israel's biggest fintech prize at Fintech Junction. The business will earn a turn over of £100m in ten years making it ready for an IPO. With the proceeds, it will create new software platforms, publishers, banks, and accounting firms.
days to go: Expired investment: £350,000
Beacon is a company that offers software and supporting services to help a client optimise their digital marketing efforts and improve their marketing Return-on-Investment (ROI). The company offers clients services like campaign management, PPC (Pay Per Click) campaign analytics, social media analytics, and anti-fraudulent click system etc. Using the company's portal, marketers can compare costs and revenue across all digital channels, channel by channel, and with their off-line marketing efforts. Beacon aims at removing ‘non-human clicks’ and giving direct independent attribution of emails, posts, ad’s, etc. to specific website actions and business goals thereby improving engagement and reducing costs. According to Stratistics Market Research Consulting, the web analytics tools market is expected to reach $4.9 billion by 2022, growing at a Compound Annual Growth Rate (CAGR) of 20.8%, in which, Beacon aims to be a leading contender. The company will use the investment to grow its business across different verticals.

Pitch Rated

75%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £240,000
On NightZookeeper.com, children create their magical animals that come to life (e.g. Tamagotchis), which teachers then use to deliver interactive lesson content. The children’s work is then sent to a teacher dashboard and automatically assessed. As well as building brand awareness and reach, the website has generated £100,000 in recurring annual subscriptions during the past 12 months.
days to go: Expired investment: £585,368
Edozo goal is to transform data storage, data sharing and workflow efficiency for commercial property professionals. 
days to go: Expired investment: £350,000
Zentraxa is focused on precision bioengineering to produce peptides with predictable properties tailored towards purpose. The company points out that peptides are amino acids that are the building blocks of certain proteins needed by the skin, like collagen and elastin. It has come out with a synthetic biology platform, Zentide, that designs, produces and tests novel peptides. Zentraxa argues that Zentide can circumvent previously existing bio-design limits imposed by conventional peptide synthesis and produce tailor-made biomaterials for healthcare, personal care and industrial uses. Zentraxa is initially targeting healthcare with its first biomaterial, a debondable adhesive, for use in wound care. The company asserts that the material has other uses such as cosmetics and industrial applications due to its ability to bond strongly while still being easily and painlessly removable. Zentraxa will use the investment to create a portfolio of other biomaterials for licensing to global businesses in the health and industrial sectors via its Zentide platform. 
days to go: Expired investment: £1,040,000
Oxford Nanoimaging (ONI) is an offshoot company, born from the biological physics lab at Oxford University, that specialises in super-resolution microscopy. Its innovation, Nanoimager, is a super-resolution fluorescence and portable microscope that is capable of real-time 3D localization analysis and rendering. It has multiple applications in a variety of fields such as viral particle imaging, quantitative cellular imaging, epigenetic mapping, and many more. ONI states that the Nanoimager can align and analyse samples, and then upload the results onto a computer for deeper graphical and data examination. ONI is also supporting the global effort into research and diagnostics to tackle the COVID-19 pandemic and finds the Nanoimager uniquely suited to this task. The company plans to use the investment to grow its business and ensure more institutions and researchers adopt its technology.
days to go: Expired investment: Withheld
Themis is a regulatory technology company that helps organisations mitigate the risk and impact of all forms of financial crime such as money laundering, bribery, corruption, cybercrime, theft, slavery/human trafficking, and fraud. The platform is designed to provide insights and intelligence on the latest threats, trends, and criminal techniques whilst helping clients complete due diligence on their clients, staff, and supply chains. Themis works alongside the Themis Charitable Trust to ensure the reduction of financial crime. The company also supports the UN Global Compact taking into account the fundamental responsibilities of business in the areas of human rights, labour, environment, and anti-corruption. Themis will use the investment to grow its business across different verticals.

Pitch Rated

37%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,300,000
Publisher Discovery, using AI & Machine Learning technologies, provides recommendations to Advertisers of highly relevant Publishers in the affiliate marketing sector. The company has built a uniquely curated database of over 2 million publishers and 330,000 advertisers, which are then analysed, compared, and matched to make recommendations in ranked lists, matching the best publishers with each advertiser. The affiliate publishing market is worth 16 billion dollars per year but is still largely dominated by human-based agencies and is uniquely suited for automation. Publisher Discovery aims to capitalise on this aspect and establish itself as the market leader. The company has signed up over 50 publishers and is negotiating contracts with two large distribution partners. It is currently raising £1 million investment with £675,000 committed so far, to grow sales and operations and reach over £2m Annual Recurring Revenue (ARR) in the following 12 months.

Pitch Rated

73%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £800,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph